Fever in neutropenia in children and adolescents: Evolution over time of main characteristics in a single center, 1993-2001

Supportive Care in Cancer

Volumn 12, Issue 12, 2004, Pages 826-832

  Ammann, Roland A ^a   Aebi, Christoph ^a   Hirt, Andreas ^a   Lüthy, Annette Ridolfi ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Antibiotic resistance; Chemotherapy; Fever in neutropenia; Risk prediction

Indexed keywords

AMIKACIN; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; CEFTRIAXONE; COTRIMOXAZOLE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; B LYMPHOCYTE; CANCER CHEMOTHERAPY; CANCER REGRESSION; CENTRAL VENOUS CATHETER; CHILD; CHILDHOOD CANCER; CHILL; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FEVER; HUMAN; INCIDENCE; INFECTION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; PNEUMONIA; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; WARD;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; FEMALE; FEVER; HUMANS; LEUKEMIA, B-CELL; MALE; NEUTROPENIA; POISSON DISTRIBUTION; RETROSPECTIVE STUDIES; SWITZERLAND;

EID: 12144270832     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-004-0660-z     Document Type: Article

References (28)

1. Alexander SW, Wade KC, Hibberd PL, Parsons SK (2002) Evaluation of risk prediction criteria for episodes of febrile neutropenia in children with cancer. J Pediatr Hematol Oncol 24:38-42
2. Alexander SW, Walsh TJ, Freifeld AG, Pizzo PA (2002) Infectious complications in pediatric cancer patients. In: Pizzo PA, Poplack DG (eds) Principles and practice of pediatric oncology. Lippincott Williams & Wilkins, Philadelphia
3. Altman DG (1991) Practical statistics for medical research. Chapman & Hall, London
4. Ammann RA, Hirt A, Ridolfi-Lüthy A, Aebi C (2003) The identification of children presenting with fever in chemotherapy-induced neutropenia at low risk for severe bacterial infection. Med Pediatr Oncol 41:436-443
5. Ammann RA, Ridolfi Lüthy A, Hirt A, Aebi C (2004) Predicting bacteremia in children with fever in chemotherapy-induced neutropenia. Pediatr Infect Dis J 23:61-67
6. Aquino VM, Pappo A, Buchanan GR, Tkaczewski I, Mustafa MM (1995) The changing epidemiology of bacteremia in neutropenic children with cancer. Pediatr Infect Dis J 14:140-143
7. Aquino VM, Herrera L, Sandler ES, Buchanan GR (2000) Feasibility of oral ciprofloxacin for the outpatient management of febrile neutropenia in selected children with cancer. Cancer 88:1710-1714
8. Baorto EP, Aquino VM, Mullen CA, Buchanan GR, DeBaun MR (2001) Clinical parameters associated with low bacteremia risk in 1100 pediatric oncology patients with fever and neutropenia. Cancer 92:909-913
9. Castagnola E, Boni L, Giacchino M, Cesaro S, De Sio L, Garaventa A, Zanazzo GA, Biddau P, Rossi MR, Schettini F, Bruzzi P, Viscoli C (2003) A multicenter, randomized, double blind placebo-controlled trial of amoxicillin/clavulanate for the prophylaxis of fever and infection in neutropenic children with cancer. Pediatr Infect Dis J 22:359-365
10. Charnas R, Ridolfi Lüthy A, Ruch W (1997) Once daily ceftriaxone plus amikacin vs. three times daily ceftazidime plus amikacin for treatment of febrile neutropenic children with cancer. Pediatr Infect Dis J 16:346-353
11. de Bont ES, Vellenga E, Swaanenburg JC, Fidler V, Visser-van Brummen PJ, Kamps WA (1999) Plasma IL-8 and IL-6 levels can be used to define a group with low risk of septicaemia among cancer patients with fever and neutropenia. Br J Haematol 107:375-380
12. Feld R, Paesmans M, Freifeld AG, Klastersky J, Pizzo PA, Rolston KV, Rubenstein E, Talcott JA, Walsh TJ (2002) Methodology for clinical trials involving patients with cancer who have febrile neutropenia: updated guidelines of the Immunocompromised Host Society/Multinational Association for Supportive Care in Cancer, with emphasis on outpatient studies. Clin Infect Dis 35:1463-1468
13. Freifeld AG, Walsh TJ, Pizzo PA (1997) Infectious complications in the pediatric cancer patient. In: Pizzo PA, Poplack DG (eds) Principles and practice of pediatric oncology, third edition. Lippincott-Raven, Philadelphia
14. Hann I, Viscoli C, Paesmans M, Gaya H, Glauser M (1997) A comparison of outcome from febrile neutropenic episodes in children compared with adults: results from four EORTC studies. Br J Haematol 99:580-588
15. Haupt R, Romanengo M, Fears T, Viscoli C, Castagnola E (2001) Incidence of septicaemias and invasive mycoses in children undergoing treatment for solid tumours: a 12-year experience at a single Italian institution. Eur J Cancer 37:2413-2419
16. Klaassen RJ, Goodmann TR, Pham B, Doyle JJ (2000) "Low-risk" prediction rule for pediatric oncology patients presenting with fever and neutropenia. J Clin Oncol 18:1012-1019
17. Klastersky J, Paesmans M, Rubenstein EB, Boyer M, Elting L, Feld R, Talcott J (2000) The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol 18:3038-3051
18. Lucas KG, Brown AE, Armstrong D, Chapman D, Heller G (1996) The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complications of sepsis. Cancer 77:791-798
19. Madsen K, Rosenman M, Hui S, Breitfeld PP (2002) Value of electronic data for model validation and refinement: bacteremia risk in children with fever and neutropenia. J Pediatr Hematol Oncol 24:256-262
20. Mullen CA, Petropoulos D, Roberts WM, Rytting M, Zipf T, Chan KW, Culbert SJ, Danielson M, Jeha SS, Kuttesch JF, Rolston KV (1999) Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients. Cancer 86:126-134
21. Pizer B, Paulus SC, Hemsworth S, van Saene R (2003) A prospective study of septicaemia in a paediatric oncology unit: A three year experience at the Royal Liverpool Children's Hospital. Med Pediatr Oncol 41:298 (O171)
22. Rackoff WR, Gonin R, Robinson C, Kreissman SG, Breitfeld PB (1996) Predicting the risk of bacteremia in children with fever and neutropenia. J Clin Oncol 14:919-924
23. Santolaya ME, Alvarez AM, Becker A, Cofré J, Enríquz N, O'Ryan M, Payá E, Pilorget J, Salgado C, Tordecilla J, Varas M, Villaroel M, Tiviani T, Zubieta M (2001) Prospective, multicenter evaluation of risk factors associated with invasive bacterial infection in children with cancer, neutropenia, and fever. J Clin Oncol 19:3415-3421
24. Shaw PJ (2002) Suspected infection in children with cancer. J Antimicrob Chemother 49 [Suppl 1]:63-67
25. Sprent P, Smeeton NC (2001) Applied nonparametric statistical methods. Chapman & Hall/CRC, Boca Raton
26. Viscoli C (2003) Management of febrile neutropenia. Med Pediatr Oncol 41:248 (KL015)
27. Viscoli C, Castagnola E, Giacchino M, Cesaro S, Properzi E, Tucci F, Mura RM, Alvisi P, Zanazzo G, Surico G, Bonetti F, De Sio L, Izzi G, Di Cataldo A, Ziino O, Massolo F, Nardi M, Santoro N, Binda S (1999) Bloodstream infections in children with cancer: a multicentre surveillance study of the Italian Association of Paediatric Haematology and Oncology. Eur J Cancer 35:770-774
28. Wehl G, Allerberger F, Heitger A, Meister B, Maurer K, Fink FM (1999) Trends in infection morbidity in a pediatric oncology ward, 1986-1995. Med Pediatr Oncol 32:336-343